Professor Koruga, Tumour Trace’s inventor of Opto-Magnetic Imaging Spectroscopy (OMIS), the technology behind the Tumour Trace device, joins the accelerator programme.
Next Business Generation is a business accelerator programme offering start-up businesses the facilities and professional expertise to develop an incredible range of skills and knowledge to improve their products and business strategies. Through a combination of business experts and partnerships with BioCity, Accelerace International and local scientific institutions, the aim of the scheme is to take businesses to the next level. Next Business Generation provides participants with professional training across all aspects of business that are essential to successfully taking products or services to market. These skills not only help foster knowledge to support current business activity, but furthermore throughout the course of an entrepreneur’s career.
Following an application process, Tumour Trace was selected to participate with Professor Djuro Koruga leading the TT team, bringing his potentially disruptive nanotechnology in the form of his early cancer screening and diagnostic prototype to Nottingham.
Nottingham City’s Councillor Nick McDonald, Portfolio Holder for Jobs, Growth and Transport said “Nottingham has a great deal to offer entrepreneurs from all over the world and we are extremely excited that Professor Koruga from Belgrade University has decided to participate in Nottingham City Councils and BioCity’s Next Business Generation accelerator programme”.